Intravitreal bevacizumab injection for central serous chorioretinopathy

Retina. 2010 Sep;30(8):1323-24; author reply 1324. doi: 10.1097/IAE.0b013e3181e46b09.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Central Serous Chorioretinopathy / diagnosis
  • Central Serous Chorioretinopathy / drug therapy*
  • Central Serous Chorioretinopathy / physiopathology
  • Coloring Agents
  • Fluorescein Angiography
  • Humans
  • Indocyanine Green
  • Injections
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Coloring Agents
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Indocyanine Green